Publicacións en colaboración con investigadores/as de Universidad de Sevilla (15)

2023

  1. Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection

    Frontiers in Medicine, Vol. 10

2019

  1. Quorum and light signals modulate acetoin/Butanediol catabolism in acinetobacterspp

    Frontiers in Microbiology, Vol. 10, Núm. JUN

  2. Reporting identification of Acinetobacter spp genomic species: A nationwide proficiency study in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 2, pp. 89-92

2018

  1. Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii

    Frontiers in Microbiology, Vol. 9

  2. Relationship between tolerance and persistence mechanisms in acinetobacter baumannii strains with abkab toxin-antitoxin system

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 5

  3. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697

2017

  1. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 9, pp. 551-558

2015

  1. Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish society of infectious diseases and clinical microbiology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 337.e1-337.e21

  2. Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 338-341

  3. Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229

2014

  1. Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal

    Medicine (United States), Vol. 93, Núm. 5, pp. 202-210

  2. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126

2013

  1. Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 4-9

  2. Erratum: Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: Segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) (Enfermedades Infecciosas y Microbiologia Clinica (2013) 31 (4-9))

    Enfermedades Infecciosas y Microbiologia Clinica